Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Remuzzi

Showing results (661-670 of 895) with videos related to

Pageof 90
Sort By:
Kidney International|February 12, 2004
In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: insights from the MY.S.S. trialNorberto Perico, Piero Ruggenenti, Eliana Gotti, et al.
Experimental Dermatology|November 7, 2006
Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patientsMacarena Gomez Lira, Lisa Provezza, Giovanni Malerba, et al.
Cells|June 10, 2022
Shiga Toxin 2 Triggers C3a-Dependent Glomerular and Tubular Injury through Mitochondrial Dysfunction in Hemolytic Uremic SyndromeSimona Buelli, Monica Locatelli, Claudia Elisa Carminati, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2008
Fractalkine and CX3CR1 mediate leukocyte capture by endothelium in response to Shiga toxinCristina Zanchi, Carla Zoja, Marina Morigi, et al.
Frontiers in Immunology|March 12, 2024
Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseasesLuca Perico, Federica Casiraghi, Fabiane Sônego, et al.
Lancet (London, England)|March 11, 2015
Rare diseases and effective treatments: are we delivering?Lucio Luzzatto, Carla E M Hollak, Timothy M Cox, et al.
Nature Communications|October 19, 2017
Human mesenchymal stromal cells transplanted into mice stimulate renal tubular cells and enhance mitochondrial functionLuca Perico, Marina Morigi, Cinzia Rota, et al.
Molecular Immunology|June 29, 2007
Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndromeDavid Kavanagh, Anna Richards, Marina Noris, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 7, 2011
Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosisMarina Morigi, Miriam Galbusera, Sara Gastoldi, et al.
Transplantation|November 20, 2002
Lymphomas occurring late after solid-organ transplantation: influence of treatment on the clinical outcomeGianpietro Dotti, Roberto Fiocchi, Teresio Motta, et al.
Pageof 90

Showing results (661-670 of 895) with videos related to

Sort By:
Pageof 90
Kidney International|February 12, 2004
In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: insights from the MY.S.S. trialNorberto Perico, Piero Ruggenenti, Eliana Gotti, et al.
Experimental Dermatology|November 7, 2006
Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patientsMacarena Gomez Lira, Lisa Provezza, Giovanni Malerba, et al.
Cells|June 10, 2022
Shiga Toxin 2 Triggers C3a-Dependent Glomerular and Tubular Injury through Mitochondrial Dysfunction in Hemolytic Uremic SyndromeSimona Buelli, Monica Locatelli, Claudia Elisa Carminati, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2008
Fractalkine and CX3CR1 mediate leukocyte capture by endothelium in response to Shiga toxinCristina Zanchi, Carla Zoja, Marina Morigi, et al.
Frontiers in Immunology|March 12, 2024
Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseasesLuca Perico, Federica Casiraghi, Fabiane Sônego, et al.
Lancet (London, England)|March 11, 2015
Rare diseases and effective treatments: are we delivering?Lucio Luzzatto, Carla E M Hollak, Timothy M Cox, et al.
Nature Communications|October 19, 2017
Human mesenchymal stromal cells transplanted into mice stimulate renal tubular cells and enhance mitochondrial functionLuca Perico, Marina Morigi, Cinzia Rota, et al.
Molecular Immunology|June 29, 2007
Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndromeDavid Kavanagh, Anna Richards, Marina Noris, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 7, 2011
Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosisMarina Morigi, Miriam Galbusera, Sara Gastoldi, et al.
Transplantation|November 20, 2002
Lymphomas occurring late after solid-organ transplantation: influence of treatment on the clinical outcomeGianpietro Dotti, Roberto Fiocchi, Teresio Motta, et al.
Pageof 90